Research programme: Tribbles homolog 1 degraders: FIMECS
Latest Information Update: 23 Jun 2023
At a glance
- Originator FIMECS
- Class Antineoplastics
- Mechanism of Action TRIB1 protein degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Acute myeloid leukaemia
Most Recent Events
- 26 Apr 2023 Investigation in Acute myeloid leukaemia in Japan (unspecified route) (FEMISC Pipeline, April 2023)